Yasuko Koda

477 total citations
22 papers, 315 citations indexed

About

Yasuko Koda is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Infectious Diseases. According to data from OpenAlex, Yasuko Koda has authored 22 papers receiving a total of 315 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Cellular and Molecular Neuroscience and 3 papers in Infectious Diseases. Recurrent topics in Yasuko Koda's work include Neuropeptides and Animal Physiology (5 papers), Cancer therapeutics and mechanisms (3 papers) and Chemical Synthesis and Analysis (2 papers). Yasuko Koda is often cited by papers focused on Neuropeptides and Animal Physiology (5 papers), Cancer therapeutics and mechanisms (3 papers) and Chemical Synthesis and Analysis (2 papers). Yasuko Koda collaborates with scholars based in Japan, Australia and United States. Yasuko Koda's co-authors include István Tóth, Joanne T. Blanchfield, Yoshio Okada, Lawrence H. Lazarus, Mitsuo Matsuda, Koji Nakamura, Kazuhiro Suda, Hajime Imai, Seiichi Era and Tomoya Hayashi and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Journal of Medicinal Chemistry and Electrochimica Acta.

In The Last Decade

Yasuko Koda

20 papers receiving 311 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yasuko Koda Japan 11 133 66 47 47 38 22 315
С. Н. Черенкевич Belarus 16 163 1.2× 26 0.4× 18 0.4× 28 0.6× 18 0.5× 39 505
H. Mizutani Japan 15 219 1.6× 30 0.5× 33 0.7× 200 4.3× 22 0.6× 27 549
Susan James Ireland 9 167 1.3× 18 0.3× 16 0.3× 18 0.4× 39 1.0× 11 326
Stephen A. Sanders United Kingdom 10 259 1.9× 16 0.2× 10 0.2× 39 0.8× 34 0.9× 15 459
Diane Tang‐Liu United States 15 163 1.2× 18 0.3× 45 1.0× 16 0.3× 19 0.5× 34 826
G Piasecka Poland 11 149 1.1× 30 0.5× 23 0.5× 30 0.6× 13 0.3× 24 526
H. Kondo Japan 10 145 1.1× 41 0.6× 22 0.5× 38 0.8× 9 0.2× 22 441
Emi Nakano Japan 11 77 0.6× 32 0.5× 23 0.5× 13 0.3× 11 0.3× 23 375
Samrein B. M. Ahmed United Arab Emirates 12 219 1.6× 33 0.5× 15 0.3× 19 0.4× 21 0.6× 29 474
James B. Kramer United States 12 178 1.3× 278 4.2× 31 0.7× 8 0.2× 27 0.7× 24 623

Countries citing papers authored by Yasuko Koda

Since Specialization
Citations

This map shows the geographic impact of Yasuko Koda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasuko Koda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasuko Koda more than expected).

Fields of papers citing papers by Yasuko Koda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasuko Koda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasuko Koda. The network helps show where Yasuko Koda may publish in the future.

Co-authorship network of co-authors of Yasuko Koda

This figure shows the co-authorship network connecting the top 25 collaborators of Yasuko Koda. A scholar is included among the top collaborators of Yasuko Koda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasuko Koda. Yasuko Koda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
White, Andrew M., Yasuko Koda, David J. Craik, et al.. (2025). Combining Bioactive Cell-Penetrating Peptides and Vemurafenib to Produce Peptide–Drug Conjugates with Activity Against Drug-Resistant Melanoma Cells. Journal of Medicinal Chemistry. 68(21). 23459–23471.
2.
White, Andrew M., et al.. (2025). Synthesis and Investigation of Peptide–Drug Conjugates Comprising Camptothecin and a Human Protein‐Derived Cell‐Penetrating Peptide. Chemical Biology & Drug Design. 105(1). e70051–e70051. 2 indexed citations
3.
4.
Yuki, Hitomi, Yasuko Koda, Yuri Tomabechi, et al.. (2017). Activity cliff for 7-substituted pyrrolo-pyrimidine inhibitors of HCK explained in terms of predicted basicity of the amine nitrogen. Bioorganic & Medicinal Chemistry. 25(16). 4259–4264. 8 indexed citations
5.
Koda, Yasuko, Akiko Tanaka, Hitomi Yuki, et al.. (2017). Identification of pyrrolo[2,3-d]pyrimidines as potent HCK and FLT3-ITD dual inhibitors. Bioorganic & Medicinal Chemistry Letters. 27(22). 4994–4998. 9 indexed citations
6.
Obando, Daniel, Namfon Pantarat, Yasuko Koda, et al.. (2009). Synthesis, antifungal, haemolytic and cytotoxic activities of a series of bis(alkylpyridinium)alkanes. Bioorganic & Medicinal Chemistry. 17(17). 6329–6339. 20 indexed citations
7.
Koda, Yasuko, et al.. (2008). Synthesis and in vitro evaluation of a library of modified endomorphin 1 peptides. Bioorganic & Medicinal Chemistry. 16(11). 6286–6296. 47 indexed citations
8.
Koda, Yasuko, Mingtao Liang, Joanne T. Blanchfield, & István Tóth. (2008). In vitro stability and permeability studies of liposomal delivery systems for a novel lipophilic endomorphin 1 analogue. International Journal of Pharmaceutics. 356(1-2). 37–43. 15 indexed citations
9.
Jacob, C.M.A., et al.. (2007). Allergic Proctocolitis Associated With Cow's Milk With An Unusual Evolution. Journal of Allergy and Clinical Immunology. 119(1). S123–S123.
10.
Ross, Benjamin P., et al.. (2007). Caco-2 cell permeability and stability of two d-glucopyranuronamide conjugates of thyrotropin-releasing hormone. Bioorganic & Medicinal Chemistry. 15(14). 4946–4950. 8 indexed citations
11.
Koda, Yasuko, et al.. (2007). Comparison of the in vitro apparent permeability and stability of opioid mimetic compounds with that of the native peptide. Bioorganic & Medicinal Chemistry Letters. 17(7). 2043–2046. 8 indexed citations
12.
Kim, In-Hae, Kosuke Nishi, Hsing-Ju Tsai, et al.. (2006). Design of bioavailable derivatives of 12-(3-adamantan-1-yl-ureido)dodecanoic acid, a potent inhibitor of the soluble epoxide hydrolase. Bioorganic & Medicinal Chemistry. 15(1). 312–323. 49 indexed citations
13.
14.
Imai, Hajime, Tomoya Hayashi, Koji Nakamura, et al.. (2002). Strenuous Exercise-Induced Change in Redox State of Human Serum Albumin during Intensive Kendo Training.. The Japanese Journal of Physiology. 52(2). 135–140. 57 indexed citations
15.
Ikezawa, Yasunari, et al.. (2000). In situ FTIR study of pyrazine adsorbed on Au(111), Au(100) and Au(110) electrodes. Electrochimica Acta. 45(13). 2075–2082. 9 indexed citations
16.
Kakiyama, Tetsuji, Yasuko Koda, & Mitsuo Matsuda. (1999). Effects of physical inactivity on aortic distensibility in visually impaired young men. European Journal of Applied Physiology. 79(3). 205–211. 11 indexed citations
17.
Akimoto, Takayuki, et al.. (1998). EFFECTS OF REPETITIOUS INTENSE EXERCISE TRAINING ON RESTING SALIVARY IGA. Japanese Journal of Physical Fitness and Sports Medicine. 47(2). 245–251. 5 indexed citations
18.
Akimoto, Takayuki, et al.. (1998). ALTERATION OF LOCAL IMMUNITY IN THE ORAL CAVITY AFTER ENDURANCE RUNNING. Japanese Journal of Physical Fitness and Sports Medicine. 47(1). 53–61. 11 indexed citations
19.
Kakiyama, Tetsuji, Yasuko Koda, Seiji Maeda, M Matsuda, & Masahiro Takaishi. (1997). ARTERIAL ELASTICITY AND PHYSICAL FITNESS LEVEL IN VISUALLY IMPAIRED YOUNG MALES 79. Medicine & Science in Sports & Exercise. 29(Supplement). 14–14. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by С. Н. Черенкевич Breakdown of academic impact, for papers by H. Mizutani Breakdown of academic impact, for papers by Susan James Breakdown of academic impact, for papers by Stephen A. Sanders Breakdown of academic impact, for papers by Diane Tang‐Liu Breakdown of academic impact, for papers by G Piasecka Breakdown of academic impact, for papers by H. Kondo Breakdown of academic impact, for papers by Emi Nakano Breakdown of academic impact, for papers by Samrein B. M. Ahmed Breakdown of academic impact, for papers by James B. Kramer
Rankless by CCL
2026